{"id":"W3133171581","doi":"10.1093/noajnl/vdab029","title":"Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastoma","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology Advances","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Lomustine; Meta-analysis; Internal medicine; Medicine; Progression-free survival; Randomized controlled trial; Oncology; Hazard ratio; Confidence interval; Bevacizumab; Glioblastoma; Overall survival; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1289388,0.002878276,0.01095468,0.006102222,0.000524961,0.005256894,0.003311006,0.002802422,0.00459181],"category_scores_gemma":[0.2966543,0.001621408,0.02133086,0.006744593,0.001500709,0.003884207,0.002517308,0.002835633,0.0003992365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003306345,"about_ca_system_score_gemma":0.00494107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006452478,"about_ca_topic_score_gemma":0.01205119,"domain_scores_codex":[0.8725026,0.1041912,0.01332936,0.005042662,0.004182158,0.0007520415],"domain_scores_gemma":[0.739392,0.2286057,0.0141026,0.009928118,0.00715698,0.0008145579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00247369,0.00004949062,0.01049818,0.2166174,0.7007563,0.0002059503,0.0003548713,0.004395482,0.0002908947,0.002958346,0.00541748,0.05598199],"study_design_scores_gemma":[0.00276234,0.0005251122,0.01246209,0.07796086,0.8633818,0.0002529004,0.000243641,0.004515064,0.0003356269,0.02062223,0.01679605,0.0001422618],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008704359,0.9638188,0.01538087,0.007402777,0.0009893987,0.0008296522,0.001581726,0.0001261558,0.001166191],"genre_scores_gemma":[0.5810319,0.3523946,0.04259825,0.01331557,0.002166865,0.004818071,0.002828907,0.0002603681,0.0005854802],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1289388,"threshold_uncertainty_score":0.6819016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3889196538014187,"score_gpt":0.5126792394070162,"score_spread":0.1237595856055975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}